Related Experiment Video
Updated: Jun 2, 2026
Gene-environment Interaction Models to Unmask Susceptibility Mechanisms in Parkinson's Disease
Published on: January 7, 2014
Regulation of the Bcas1 and Baiap3 transcripts in the subthalamic nucleus in mice recovering from MPTP toxicity
J B Lauridsen1, J L Johansen, J C Rekling
1Department of Neuroscience and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Panum Institute, Blegdamsvej 3, DK-2200 Copenhagen, Denmark. JBRL@lundbeck.com
Abstract:
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) exposure leads to significant and irreversible damage to dopaminergic neurons in both mice and humans. While MPTP exposure in humans causes permanent symptoms of Parkinson's disease, MPTP treated mice will recover behaviorally over a 3-week period. This mouse specific recovery might be linked to transcriptional changes in the basal ganglia enabling mice to maintain normal motor function in spite of low striatal dopamine levels. Laser microdissection was used to isolate the subthalamic nucleus from mice 7 and 28 days following MPTP exposure. High quality RNA was recovered and expressional analysis was performed on whole mouse genome microarrays. Identified regulated transcripts were validated in a separate batch of animals using quantitative PCR. Two transcripts with a significant regulation from days 7 to 28 in the MPTP treated groups, were identified: the brain specific angiogenesis inhibitor associated protein 3 (Baiap3) and the breast carcinoma amplified sequence 1 (Bcas1). Further studies of the molecular pathways involving these two transcripts may uncover processes in the subthalamic nucleus associated with the behavioral recovery observed after MPTP exposure.
Insights
MPTP exposure damages dopamine neurons, but mice recover behaviorally. This recovery may involve specific gene expression changes in the brain, identified as Baiap3 and Bcas1, offering insights into Parkinson's disease mechanisms.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) causes irreversible dopaminergic neuron damage.
- Human MPTP exposure results in permanent Parkinson's disease symptoms.
- Mice exhibit behavioral recovery from MPTP exposure, suggesting underlying adaptive mechanisms.
Purpose of the Study:
- Investigate transcriptional changes in the mouse subthalamic nucleus following MPTP exposure.
- Identify specific genes associated with behavioral recovery in MPTP-treated mice.
- Explore potential molecular pathways involved in the resilience of the mouse basal ganglia.
Main Methods:
- Laser microdissection to isolate the subthalamic nucleus from MPTP-treated mice at 7 and 28 days post-exposure.
- Whole mouse genome microarray analysis to assess gene expression.
- Quantitative PCR for validation of identified transcripts.
Main Results:
- Two transcripts, brain specific angiogenesis inhibitor associated protein 3 (Baiap3) and breast carcinoma amplified sequence 1 (Bcas1), showed significant regulation between days 7 and 28 in MPTP-treated mice.
- These genes were identified as potentially involved in the mouse-specific recovery process.
- Transcriptional changes were observed in the subthalamic nucleus, a key component of the basal ganglia.
Conclusions:
- The identified transcripts Baiap3 and Bcas1 may play a role in the subthalamic nucleus's adaptation to MPTP-induced neurotoxicity.
- Further research into the molecular pathways of these genes could reveal novel insights into Parkinson's disease recovery mechanisms.
- Understanding these mouse-specific recovery processes may inform future therapeutic strategies for neurodegenerative disorders.
